AbCellera Biologics Inc. (ABCL)

NASDAQ: ABCL · IEX Real-Time Price · USD

2.970

-0.090 (-2.94%)

At close: Jul 19, 2024, 4:00 PM

3.000

+0.030 (1.01%)

Pre-market: Jul 22, 2024, 7:02 AM EDT

AbCellera Biologics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018
Revenue	35.79	38.03	485.42	375.2	233.16	11.61	Upgrade
Revenue Growth (YoY)	-80.23%	-92.17%	29.38%	60.92%	1907.88%	31.49%	Upgrade
Gross Profit	35.79	38.03	485.42	375.2	233.16	11.61	Upgrade
Selling, General & Admin	76.99	75.18	66.76	48.76	15.75	4.01	Upgrade
Research & Development	162.3	175.66	107.88	62.06	29.39	10.11	Upgrade
Other Operating Expenses	23.73	24.4	94.28	59.97	31.98	1.6	Upgrade
Operating Expenses	263.01	275.23	268.91	170.79	77.12	15.73	Upgrade
Operating Income	-227.23	-237.21	216.51	204.41	156.03	-4.12	Upgrade
Interest Expense / Income	0	0	0	0	6.81	0.21	Upgrade
Other Expense / Income	-58.6	-63.18	-22.59	-14.74	-8.61	-2.12	Upgrade
Pretax Income	-168.63	-174.03	239.1	219.15	157.83	-2.21	Upgrade
Income Tax	-21.73	-27.63	80.58	65.69	38.92	0	Upgrade
Net Income	-146.9	-146.4	158.52	153.46	118.92	-2.21	Upgrade
Net Income Growth	-	-	3.29%	29.05%	-	-	Upgrade
Shares Outstanding (Basic)	293	289	285	276	159	151	Upgrade
Shares Outstanding (Diluted)	293	289	315	318	263	151	Upgrade
Shares Change	1.72%	-8.15%	-1.09%	20.96%	73.88%	-11.68%	Upgrade
EPS (Basic)	-0.52	-0.51	0.56	0.56	0.53	-0.01	Upgrade
EPS (Diluted)	-0.52	-0.51	0.50	0.48	0.45	-0.01	Upgrade
EPS Growth	-	-	4.17%	6.67%	-	-	Upgrade
Free Cash Flow	-127.63	-120.82	206.7	186.13	13.02	-1.3	Upgrade
Free Cash Flow Per Share	-0.44	-0.42	0.72	0.68	0.08	-0.01	Upgrade
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	Upgrade
Operating Margin	-634.92%	-623.82%	44.60%	54.48%	66.92%	-35.45%	Upgrade
Profit Margin	-410.47%	-385.00%	32.66%	40.90%	51.00%	-19.04%	Upgrade
Free Cash Flow Margin	-356.61%	-317.75%	42.58%	49.61%	5.58%	-11.22%	Upgrade
Effective Tax Rate	-	-	33.70%	29.97%	24.66%	-	Upgrade
EBITDA	-138.09	-143.14	272.2	236.4	169.92	-0.16	Upgrade
EBITDA Margin	-385.85%	-376.42%	56.07%	63.01%	72.88%	-1.33%	Upgrade
Depreciation & Amortization	30.54	30.89	33.1	17.25	5.27	1.85	Upgrade
EBIT	-168.63	-174.03	239.1	219.15	164.64	-2	Upgrade
EBIT Margin	-471.19%	-457.67%	49.26%	58.41%	70.62%	-17.24%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).